Yorktown Management & Research Company’s Emergent Biosolutions EBS Stock Holding History

Yorktown Management & Research Company’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,200	Closed	-$411K	–	256
2021 Q3	$411K	Hold	8,200	–	–	0.31%	137
2021 Q2	$517K	Buy	8,200 +3,800	+86%	+$244K	0.41%	83
2021 Q1	$409K	Hold	4,400	–	–	0.34%	101
2020 Q4	$394K	Hold	4,400	–	–	0.35%	136
2020 Q3	$455K	Hold	4,400	–	–	0.43%	66
2020 Q2	$348K	Hold	4,400	–	–	0.31%	104
2020 Q1	$255K	Hold	4,400	–	–	0.26%	155
2019 Q4	$237K	Hold	4,400	–	–	0.13%	243
2019 Q3	$230K	Hold	4,400	–	–	0.12%	255
2019 Q2	$213K	Hold	4,400	–	–	0.08%	273
2019 Q1	$222K	Hold	4,400	–	–	0.07%	291
2018 Q4	$261K	Sell	4,400 -1,600	-27%	-$103K	0.09%	264
2018 Q3	$395K	Hold	6,000	–	–	0.12%	186
2018 Q2	$303K	Sell	6,000 -2,600	-30%	-$135K	0.09%	264
2018 Q1	$453K	Hold	8,600	–	–	0.13%	149
2017 Q4	$400K	Hold	8,600	–	–	0.12%	169
2017 Q3	$348K	Hold	8,600	–	–	0.09%	167
2017 Q2	$292K	Hold	8,600	–	–	0.09%	162
2017 Q1	$250K	Hold	8,600	–	–	0.07%	259
2016 Q4	$282K	Buy	+8,600	New	+$258K	0.07%	168

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Yorktown Management & Research Company's EBS Position: Q4 2021 in Review

Yorktown Management & Research Company sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 8,200 shares — an estimated $411K sold.

Yorktown Management & Research Company first reported a position in EBS in Q4 2016 and held it in 20 quarters. The position peaked at $517K in Q2 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Yorktown Management & Research Company reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Yorktown Management & Research Company sold 8,200 Emergent Biosolutions shares in Q4 2021, an estimated $411K.
Yorktown Management & Research Company first reported a position in Emergent Biosolutions in Q4 2016 and held it in 20 quarters.
Yorktown Management & Research Company's Emergent Biosolutions position peaked at $517K in Q2 2021.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Yorktown Management & Research Company's 13F filing for Q4 2021, filed 9 Feb 2022.